Regnante Keith
Keros Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
Regnante Keith is listed in public filings as officer: CHIEF FINANCIAL OFFICER. This Regnante Keith insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Keros Therapeutics, Inc. (KROS). Investors use Regnante Keith's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $931k60k shares | Grant / ExerciseFeb 24, 2026 | $931.2K60k shares | $15.52 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $642k39.3k shares | SellFeb 18, 2026 | $77.5K4.7k shares | $16.35 | -- | |
| --44k shares | Grant / ExerciseFeb 18, 2025 | Disclosure amount unavailable44k shares | -- | -- |